Olon Group has strengthened its CDMO capabilities with the acquisition of GTP Bioways Group, a French company operating as Biotech CDMO and specializing in R&D services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and fill-finish.
GTP Bioways operates a total of four sites in France (Toulouse, Labege, Veyre-Monton, and Saint-Julien-en-Genevois) focused on development, clinical trial and cGMP manufacturing. The headquarters are based in…
Read More…